← Back to Search

Procedure

Single vs Multiple Arterial Grafts for Heart Disease (ROMA Trial)

Toronto, Canada
N/A
Waitlist Available
Led By Mario Gaudino, MD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Primary isolated CABG patients with disease of the left main coronary artery and/or of the left anterior descending and the circumflex coronary system with or without disease of the right coronary artery.
Be older than 18 years old
Must not have
Inability to use the saphenous vein or to use both radial and right internal thoracic arteries
Anticipated need for coronary thrombo-endarterectomy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up analysis will be performed after 631 events. the investigators assume this will occur at a mean follow-up of 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether using multiple arterial grafts (2+) is better than using a single arterial graft for coronary artery bypass surgery in terms of reducing the composite outcome of death from any cause, any stroke, post discharge myocardial infarction and/or repeat revascularization.

See full description
Who is the study for?
This trial is for patients with coronary artery disease who need non-emergency heart bypass surgery and haven't had previous cardiac surgeries. It's not for those over 70, with recent heart attacks, severe heart failure, or other serious health issues that could limit life expectancy to under 5 years.Check my eligibility
What is being tested?
The ROMA trial is testing if using multiple arterial grafts in heart bypass surgery is better than a single graft at reducing death, strokes, heart attacks, and the need for more surgery. Patients are randomly assigned to either group in equal numbers across international centers.See study design
What are the potential side effects?
While specific side effects aren't listed here, typical risks of bypass surgery may include bleeding, infection, reactions to anesthesia, blood clots leading to stroke or lung problems; irregular heartbeat; and kidney problems.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have heart disease affecting specific arteries.
 show original

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I cannot use my saphenous vein or both my radial and right internal thoracic arteries.
 show original
Select...
I am expected to need surgery to remove blockages from my heart's arteries.
 show original
Select...
I am undergoing or have undergone other heart or non-heart related surgeries.
 show original
Select...
I do not have severe organ problems or other conditions that would shorten my life to under 5 years.
 show original
Select...
I am scheduled for a combined surgical and non-surgical procedure to improve blood flow.
 show original
Select...
I need an emergency surgery.
 show original
Select...
I have not had a heart attack within 2 days before surgery.
 show original
Select...
I have had heart surgery in the past.
 show original
Select...
I am over 70 years old.
 show original

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~analysis will be performed after 631 events. the investigators assume this will occur at a mean follow-up of 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and analysis will be performed after 631 events. the investigators assume this will occur at a mean follow-up of 5 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Composite Outcome
Secondary study objectives
30-day mortality
Heart
Composite Outcome of Death from any cause
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Single Arterial GroupExperimental Treatment1 Intervention
Patients in this group will receive a single arterial graft which will be the left internal thoracic artery. Additional grafts used in this group will all be venous grafts.
Group II: Multiple Arterial GroupExperimental Treatment1 Intervention
Patients in the group will receive multiple arterial grafts. All patients will receive at least two arterial grafts, the left internal thoracic artery with the addition of either the right internal thoracic artery or the radial artery as the second conduit. Some patients may receive additional arterial grafts consisting of the radial artery, the right internal thoracic artery, or the right gastroepiploic artery.

Find a Location

Closest Location:Nebraska Heart Hospital· Lincoln, NE· 217 miles

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,101 Previous Clinical Trials
1,152,571 Total Patients Enrolled
15 Trials studying Coronary Artery Disease
44,143 Patients Enrolled for Coronary Artery Disease
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,980 Previous Clinical Trials
47,861,913 Total Patients Enrolled
167 Trials studying Coronary Artery Disease
265,647 Patients Enrolled for Coronary Artery Disease
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,409 Previous Clinical Trials
26,536,120 Total Patients Enrolled
25 Trials studying Coronary Artery Disease
25,178 Patients Enrolled for Coronary Artery Disease
Mario Gaudino, MDPrincipal InvestigatorWeill Medical College of Cornell University
2 Previous Clinical Trials
2,420 Total Patients Enrolled
1 Trials studying Coronary Artery Disease
2,000 Patients Enrolled for Coronary Artery Disease
Stephen Fremes, MDPrincipal InvestigatorSunnybrook Health Sciences Centre
3 Previous Clinical Trials
2,265 Total Patients Enrolled
3 Trials studying Coronary Artery Disease
2,265 Patients Enrolled for Coronary Artery Disease

Media Library

Multiple Arterial Grafting (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT03217006 — N/A
Coronary Artery Disease Research Study Groups: Single Arterial Group, Multiple Arterial Group
Coronary Artery Disease Clinical Trial 2023: Multiple Arterial Grafting Highlights & Side Effects. Trial Name: NCT03217006 — N/A
Multiple Arterial Grafting (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03217006 — N/A
~1027 spots leftby Jun 2027